139 related articles for article (PubMed ID: 27476455)
1. Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds.
Orogo AM; Choi SS; Minnier BL; Kruhlak NL
Mol Inform; 2012 Oct; 31(10):725-39. PubMed ID: 27476455
[TBL] [Abstract][Full Text] [Related]
2. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Kruhlak NL; Choi SS; Contrera JF; Weaver JL; Willard JM; Hastings KL; Sancilio LF
Toxicol Mech Methods; 2008; 18(2-3):217-27. PubMed ID: 20020916
[TBL] [Abstract][Full Text] [Related]
3. In Silico Studies of the Relationship Between Chemical Structure and Drug Induced Phospholipidosis.
Przybylak KR; Cronin MT
Mol Inform; 2011 May; 30(5):415-29. PubMed ID: 27467088
[TBL] [Abstract][Full Text] [Related]
4. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.
Contrera JF; Kruhlak NL; Matthews EJ; Benz RD
Regul Toxicol Pharmacol; 2007 Dec; 49(3):172-82. PubMed ID: 17703860
[TBL] [Abstract][Full Text] [Related]
5. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
6. In silico modeling to predict drug-induced phospholipidosis.
Choi SS; Kim JS; Valerio LG; Sadrieh N
Toxicol Appl Pharmacol; 2013 Jun; 269(2):195-204. PubMed ID: 23541745
[TBL] [Abstract][Full Text] [Related]
7. Computational identification of a phospholipidosis toxicophore using (13)C and (15)N NMR-distance based fingerprints.
Slavov SH; Wilkes JG; Buzatu DA; Kruhlak NL; Willard JM; Hanig JP; Beger RD
Bioorg Med Chem; 2014 Dec; 22(23):6706-6714. PubMed ID: 25228124
[TBL] [Abstract][Full Text] [Related]
8. Construction and application of (Q)SAR models to predict chemical-induced in vitro chromosome aberrations.
Hsu CW; Hewes KP; Stavitskaya L; Kruhlak NL
Regul Toxicol Pharmacol; 2018 Nov; 99():274-288. PubMed ID: 30278198
[TBL] [Abstract][Full Text] [Related]
9. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
10. How does the quality of phospholipidosis data influence the predictivity of structural alerts?
Przybylak KR; Alzahrani AR; Cronin MT
J Chem Inf Model; 2014 Aug; 54(8):2224-32. PubMed ID: 25062434
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach.
Goracci L; Buratta S; Urbanelli L; Ferrara G; Di Guida R; Emiliani C; Cross S
Eur J Med Chem; 2015 Mar; 92():49-63. PubMed ID: 25544686
[TBL] [Abstract][Full Text] [Related]
12. Modeling phospholipidosis induction: reliability and warnings.
Goracci L; Ceccarelli M; Bonelli D; Cruciani G
J Chem Inf Model; 2013 Jun; 53(6):1436-46. PubMed ID: 23692521
[TBL] [Abstract][Full Text] [Related]
13. Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in Rodents.
Matthews EJ; Kruhlak NL; Benz RD; Contrera JF; Marchant CA; Yang C
Toxicol Mech Methods; 2008; 18(2-3):189-206. PubMed ID: 20020914
[TBL] [Abstract][Full Text] [Related]
14. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
[TBL] [Abstract][Full Text] [Related]
15. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
[TBL] [Abstract][Full Text] [Related]
16. Validity and validation of expert (Q)SAR systems.
Hulzebos E; Sijm D; Traas T; Posthumus R; Maslankiewicz L
SAR QSAR Environ Res; 2005 Aug; 16(4):385-401. PubMed ID: 16234178
[TBL] [Abstract][Full Text] [Related]
17. Notification: Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds.
Orogo AM; Choi SS; Minnier BL; Kruhlak NL
Mol Inform; 2013 Jan; 32(1):121. PubMed ID: 27481029
[No Abstract] [Full Text] [Related]
18. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
Tilmant K; Gerets HH; Dhalluin S; Hanon E; Depelchin O; Cossu-Leguille C; Vasseur P; Atienzar FA
Toxicol In Vitro; 2011 Oct; 25(7):1414-24. PubMed ID: 21515356
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals.
Matthews EJ; Kruhlak NL; Daniel Benz R; Ivanov J; Klopman G; Contrera JF
Regul Toxicol Pharmacol; 2007 Mar; 47(2):136-55. PubMed ID: 17175082
[TBL] [Abstract][Full Text] [Related]
20. Validation of the (Q)SAR combination approach for mutagenicity prediction of flavor chemicals.
Ono A; Takahashi M; Hirose A; Kamata E; Kawamura T; Yamazaki T; Sato K; Yamada M; Fukumoto T; Okamura H; Mirokuji Y; Honma M
Food Chem Toxicol; 2012 May; 50(5):1538-46. PubMed ID: 22369964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]